Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
Beutels P, Edmunds WJ, Antoñanzas F, De Wit GA, Evans D, Feilden R, Fendrick AM, Ginsberg GM, Glick HA, Mast E, Péchevis M, Van Doorslaer EK, van Hout BA; Viral Hepatitis Prevention Board.
Beutels P, et al.
Pharmacoeconomics. 2002;20(1):1-7. doi: 10.2165/00019053-200220010-00001.
Pharmacoeconomics. 2002.
PMID: 11817988
Review.